🧬Top Biotechnology ETFs to Boost Your Portfolio in 2024

In partnership with

Hello, ETF UNO community! If you want to add excitement to your investment portfolio this weekend, you've come to the right place. Today, we're delving into biotechnology, which has generated much interest in the investment community. So grab your lab coats (or just your favourite comfy chair), and let's explore the world of biotech ETFs!

🦾 Master AI & ChatGPT for FREE in just 3 hours 🤯

1 Million+ people have attended, and are RAVING about this AI Workshop.
Don’t believe us? Attend it for free and see it for yourself.

Save your spot here. (100 free spots only)

Highly Recommended: 🚀

Join this 3-hour Power-Packed Masterclass worth $399 for absolutely free and learn 20+ AI tools to become 10x better & faster at what you do

👉Save your seat  now (FREE for First 100)

🗓️ Tomorrow | ⏱️ 10 AM EST

In this Masterclass, you’ll learn how to:

🚀 Do quick excel analysis & make AI-powered PPTs 
🚀 Build your own personal AI assistant to save 10+ hours
🚀 Become an expert at prompting & learn 20+ AI tools
🚀 Research faster & make your life a lot simpler & more…

👉 Register here (Offer valid for First 100 people only)🎁

Why Biotech ETFs? It's All About Timing and Potential

Biotechnology is making groundbreaking advancements that can revolutionise healthcare. You might ask, "Why consider biotech ETFs now?" The answer lies in economic conditions and technological progress. Let's break it down:

The Federal Reserve has recently decreased interest rates, which can significantly impact various sectors, including biotechnology. Historically, when interest rates go down, it's often good news for news for biotech companies.

• Cheaper borrowing: Biotech firms often need lots of capital for research and development. Lower interest rates mean they can borrow money more cheaply, potentially boosting their profitability.

• Increased risk appetite: When low interest rates, investors often look for higher returns in riskier assets. Biotech, with its potential for breakthrough discoveries, becomes more attractive.

• Historical performance: Biotech stocks have often outperformed the broader market in past periods of low interest rates.

Now, let's talk about Artificial Intelligence. AI isn't just for chatbots and self-driving cars anymore; it's significantly impacting biotechnology. Here's how:

• Drug discovery acceleration: AI is revolutionising the identification of potential drug candidates, accelerating the time it takes to bring new therapies to market.

• Personalised medicine: AI enables the development of tailored treatments based on an individual's genetic makeup, improving efficacy and reducing side effects.

• Protein folding breakthroughs: AI models like AlphaFold have made significant strides in predicting protein structures, which is crucial for understanding diseases and developing new treatments.

• Operational Efficiency: From automating laboratory processes to optimising clinical trials, AI enhances the overall efficiency of biotech companies, leading to cost savings and increased productivity.

Combining AI and biotech could lead to a new era of medical breakthroughs. As investors, we can benefit from this exciting convergence through biotech ETFs.

🔝Top Biotechnology ETFs

1. SPDR S&P Biotech ETF (XBI)

Expense Ratio: 0.35%

Provider: SPDR

Past 5 Years Annualised Performance: 4.82%

XBI tracks an equal-weighted index of US biotech stocks, offering exposure to large caps and smaller, potentially high-growth companies.

2. iShares Biotechnology ETF (IBB)

Expense Ratio: 0.45%

Provider: iShares

Past 5 Years Annualised Performance: 4.96%

Already covered in our article, IBB exposes US biotechnology and pharmaceutical companies with a tilt towards larger, more established firms.

3. Invesco Nasdaq Biotechnology ETF (IBBQ)

Expense Ratio: 0.19%

Provider: Invesco

Past 5 Years Annualised Performance: N/A (the inception date of the ETF was 2021-06-11)

IBBQ tracks the Nasdaq Biotechnology Index, offering exposure to biotech and pharmaceutical companies listed on the Nasdaq.

4. iShares Genomics Immunology and Healthcare ETF (IDNA)

Expense Ratio: 0.47%

Provider: iShares

Past 5 Years Annualised Performance: -2.37%

Another ETF from iShares, IDNA focuses on companies at the forefront of genomics, immunology, and bioengineering, offering a more targeted approach to biotech investing.

5. ARK Genomic Revolution ETF (ARKG)

Expense Ratio: 0.75%

Provider: ARK

Past 5 Years Annualised Performance: -6.56%

Like other ETFs by ARK, ARKG is an actively managed ETF that focuses on companies expected to benefit from advancements in genomic science.

Investing in Innovation🚀

Biotechnology ETFs offer a unique opportunity to invest in a sector that is driving innovation in healthcare and benefiting from favourable economic conditions and technological advancements like AI. With the Federal Reserve’s recent interest rate cuts and the burgeoning role of AI in biotech, these ETFs could be poised for substantial growth.

We hope you enjoyed this simple weekend read and found it entertaining and informative. Join the ETF UNO community today to help you confidently and efficiently achieve your financial goals.

Happy investing, ETF explorers!

DISCLAIMER: This article is for informational purposes only and does not constitute investment advice. Always conduct your own research and consider consulting with a financial advisor before making investment decisions.